Jonathan G Seidman
Overview
Explore the profile of Jonathan G Seidman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
11146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maatz H, Lindberg E, Adami E, Lopez-Anguita N, Perdomo-Sabogal A, Cocera Ortega L, et al.
Nat Cardiovasc Res
. 2025 Feb;
PMID: 39994453
Myocarditis, characterized by inflammatory cell infiltration, can have multiple etiologies, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or, rarely, mRNA-based coronavirus disease 2019 (COVID-19) vaccination. The underlying cellular...
2.
Talukdar M, Chmatal L, Mao L, Reichart D, Murashige D, Skaletsky H, et al.
Circulation
. 2025 Feb;
151(7):511-514.
PMID: 39960981
No abstract available.
3.
Raj Murthi S, Petry A, Shashikadze B, Stockl J, Schmid M, Santamaria G, et al.
Sci Rep
. 2025 Jan;
15(1):2132.
PMID: 39820339
Hypertrophic cardiomyopathy (HCM) caused by autosomal-dominant mutations in genes coding for structural sarcomeric proteins, is the most common inherited heart disease. HCM is associated with myocardial hypertrophy, fibrosis and ventricular...
4.
Wang B, Morsink M, Kim S, Luo L, Zhang X, Soni R, et al.
J Clin Invest
. 2025 Jan;
135(1).
PMID: 39744939
Loss of Bcl2-associated athanogene 3 (BAG3) is associated with dilated cardiomyopathy (DCM). BAG3 regulates sarcomere protein turnover in cardiomyocytes; however, the function of BAG3 in other cardiac cell types is...
5.
Li K, Quiat D, She F, Liu Y, He R, Haghighi A, et al.
Genet Med Open
. 2024 Dec;
2:101817.
PMID: 39669606
Facioscapulohumeral dystrophy type 1 (FSHD1) is a progressive, debilitating skeletal myopathy that requires a multimodal approach for complete molecular characterization of pathogenic genotypes. Here, we report genomic analyses of a...
6.
Kip P, Sluiter T, MacArthur M, Tao M, Kruit N, Mitchell S, et al.
Nat Commun
. 2024 Nov;
15(1):9652.
PMID: 39511181
Short-term preoperative methionine restriction (MetR) is a promising translatable strategy to mitigate surgical injury response. However, its application to improve post-interventional vascular remodeling remains underexplored. Here we find that MetR...
7.
Ewoldt J, Wang M, McLellan M, Cloonan P, Chopra A, Gorham J, et al.
Sci Adv
. 2024 Oct;
10(42):eadi6927.
PMID: 39413182
Hypertrophic cardiomyopathy (HCM) is characterized by thickening of the left ventricular wall, diastolic dysfunction, and fibrosis, and is associated with mutations in genes encoding sarcomere proteins. While in vitro studies...
8.
Bhattacharya R, Ward T, Kalejaiye T, Mishra A, Leeman S, Arzaghi H, et al.
bioRxiv
. 2024 Aug;
PMID: 39211233
Early developmental programming involves extensive cell lineage diversification through shared molecular signaling networks. Clinical observations of congenital heart disease (CHD) patients carrying genetic variants revealed correlations with multi-organ impairments at...
9.
Diaz-Gil D, Silva-Gomez N, Morton S, Seidman J, Seidman C, Zurakowski D, et al.
J Thorac Cardiovasc Surg
. 2024 Aug;
169(2):366-374.
PMID: 39208926
Background: Endocardial fibroelastosis (EFE) is a major effector in the maldevelopment of the heart in patients with congenital heart disease. Despite successful surgical removal, EFE can redevelop, but the underlying...
10.
Sweat M, Cao Y, Zhang X, Burnicka-Turek O, Perez-Cervantes C, Kulandaisamy A, et al.
Nat Cardiovasc Res
. 2024 Aug;
2(11):1095.
PMID: 39196102
No abstract available.